TRICARE Pharmacy Program RFI (Draft Section C & H)

SOL #: 09ca7ec9fa2a40cba7cac54e169a5b7fSpecial Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Health Agency (Dha)
DEFENSE HEALTH AGENCY
AURORA, CO, 80011, United States

Place of Performance

Place of performance not available

NAICS

Direct Health and Medical Insurance Carriers (524114)

PSC

Medical Managed Healthcare (Q201)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 21, 2026
2
Action Date
May 22, 2026, 6:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Health Agency (DHA) is conducting acquisition planning for the next generation TRICARE Pharmacy Program (TPharm6) contract. This is a Special Notice (RFI) seeking industry feedback on draft Section C (Statement of Work) and Section H (Special Contract Requirements). The program aims to provide comprehensive pharmacy services for approximately 9.5 million beneficiaries. Feedback and requests for one-on-one meetings are due by May 22, 2026, 12:00 PM Mountain Time.

Purpose & Scope

The objective is to administer the TRICARE Pharmacy Benefits Program, ensuring high-quality, cost-effective pharmacy services. The scope includes:

  • Processing claims from various sources (retail, Mail Order Pharmacy (TMOP), Military Treatment Facilities (MTF), VA, Indian Health Services, State Medicaid Agencies).
  • Administering a retail pharmacy network across the 50 states, DC, and U.S. territories.
  • Operating the TRICARE Mail Order Pharmacy (TMOP) program.
  • Performing claims adjudication, including eligibility, cost-sharing, Other Health Insurance (OHI) identification, and Drug Utilization Review (DUR).
  • Managing clinical reviews, beneficiary and pharmacy support services, and ensuring system security and reliability.
  • Supporting interfaces with government systems (e.g., DEERS, PDW, OMDS, Federal EHR).

Key Draft Documents

  • Section C (Statement of Work): Details the program's objective, comprehensive scope of work, and numerous performance standards. These include 99.5% system availability, timely processing of reimbursement claims (95% within 10 days), and specific mail order prescription shipping times. It also outlines special requirements such as compliance with TRICARE policy, DoD Uniform Formulary, HIPAA, and the development of Quality Management and Continuity of Operations Plans.
  • Section H (Special Contract Requirements): Outlines critical contractual terms including Organizational Conflicts of Interest (OCI) disclosure, cost control incentives based on drug pricing and dispensing fees, and extensive performance guarantees. These guarantees cover areas like Mail Order Pharmacy processing, system availability, clinical review, telephone service, and claims compliance/accuracy reviews, with associated financial penalties for non-compliance.

Submission & Meetings

  • Comments and Questions: Must be submitted no later than May 22, 2026, 12:00 PM MT to dha.buckley.AD-SPT-CAE.mbx.tpharm6@health.mil. Include "Your Company Name and Draft Documents Response" in the subject line. A feedback document (TPharm6 feedback document.xlsx) is provided for structured input.
  • One-on-One Meetings: Requests must be submitted by May 22, 2026, 12:00 PM MT via the link: https://forms.osi.apps.mil/r/zBn9EyRm0g. Meetings will be facilitated in summer 2026.

Contract Details

People

Points of Contact

Files

Files

Download
Download
Download

Versions

Version 1Viewing
Special Notice
Posted: Apr 21, 2026
TRICARE Pharmacy Program RFI (Draft Section C & H) | GovScope